ClinConnect ClinConnect Logo
Search / Trial NCT03240965

Changes in Sensitivity, Taste and Smell in Stroke Patients

Launched by UNIVERSITY OF GIESSEN · Aug 1, 2017

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how a recent stroke can affect a person’s ability to swallow, as well as their sense of taste and smell. The researchers will look at stroke patients who have had a new stroke within the last 72 hours. They will use special tests to evaluate how well patients can swallow and how sensitive they are to tastes and smells. Younger and older healthy volunteers will also participate to help compare results.

To be eligible for this study, stroke patients must be able to give their consent and have a recent stroke confirmed by a brain scan. However, those with previous strokes or swallowing difficulties, certain brain issues, allergies to smells or flavors, or those who cannot undergo specific tests will not be part of the trial. Participants will have the opportunity to contribute to important research that may help improve understanding of how strokes impact swallowing and sensory experiences.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Volunteers:
  • informed consent
  • Stroke patients:
  • informed consent
  • new supratentorial stroke (\<72 hours old) confirmed by CT (computed tomography) or MRI (magnetic resonance imaging)
  • Exclusion Criteria:
  • pre-existing stroke oder dysphagia
  • extensive white matter lesions in CT- or MRI-scan
  • allergies to odorous substances or flavoring
  • contraindications for FEES (flexible endoscopic evaluation of swallowing), CT or MRI (stroke patients only)

About University Of Giessen

The University of Giessen, a prominent research institution in Germany, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including medicine, pharmacology, and public health, to conduct rigorous studies aimed at improving patient outcomes. Committed to maintaining the highest ethical standards and regulatory compliance, the University of Giessen fosters a research environment that encourages scientific inquiry and the translation of findings into clinical practice, ultimately contributing to the advancement of healthcare and therapeutic strategies.

Locations

Gießen, Hessen, Germany

Patients applied

0 patients applied

Trial Officials

Tobias Braun, M.D.

Principal Investigator

University Giessen

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials